International Journal of Technology Assessment in Health Care

Papers
(The H4-Index of International Journal of Technology Assessment in Health Care is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations117
Patient and public involvement in health technology assessment: update of a systematic review of international experiences27
The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews26
The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses25
Health technology assessment for digital technologies that manage chronic disease: a systematic review25
Development of a checklist to guide equity considerations in health technology assessment21
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal19
Environmental impact assessment in health technology assessment: principles, approaches, and challenges15
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements15
Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach14
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements13
An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency13
Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI)13
Considering and communicating uncertainty in health technology assessment13
Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer13
Mind the evidence gap: the use of patient-based evidence to create “complete HTA” in the twenty-first century13
Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story13
0.054883003234863